

Qinesca
"Advancing drug safety with end to end pharmacovigilance technology and services"
About Qinesca
Qinecsa provides pharmacovigilance solutions combining technology with scientific expertise to help pharmaceutical companies ensure drug safety and regulatory compliance. The company offers case management, signal detection, literature screening, and medical writing, supported by platforms including Reportum for case intake, HaloPV for safety management, and Vigilance Workbench. Serving life science companies of all sizes, Qinecsa manages case safety reports, aggregate reporting, risk management, and surveillance globally. With over 1,300 specialists in Europe, North America, and Asia, the company supports clients through the pharmacovigilance lifecycle, helping navigate regulatory requirements while keeping patient safety at the centre.


1300
Team Members
2006
Founded
Private Equity
Funding
Hybrid
Work Environment
A world where pharmaceutical innovation proceeds with complete confidence in patient safety, supported by intelligent technology and expert human oversight that anticipates risks before they emerge and protects lives across all markets.
At Qinecsa, our mission is to create a safer and healthier world for patients by providing pharmaceutical companies with technology enabled pharmacovigilance solutions that ensure regulatory compliance and safeguard product safety.